Legal Representation
Attorney
KENNETH F FLOREK
USPTO Deadlines
Next Deadline
602 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-03-23)
Due Date
March 23, 2027
Grace Period Ends
September 23, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
49 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 28, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Aug 14, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jul 1, 2021 | XXCR | P | GENERIC MADRID TRANSACTION CREATED | Loading... |
| Jul 1, 2021 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
| Jun 23, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Mar 23, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 16, 2021 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Feb 16, 2021 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Feb 16, 2021 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Dec 26, 2020 | RFNP | P | REFUSAL PROCESSED BY IB | Loading... |
| Dec 7, 2020 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Dec 1, 2020 | OPNC | E | OPPOSITION NOTICE (IB REFUSAL) CREATED | Loading... |
| Dec 1, 2020 | OPNS | B | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | Loading... |
| Oct 10, 2020 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Sep 23, 2020 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Sep 23, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jun 30, 2020 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jun 2, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 2, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 29, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| May 13, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 13, 2020 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| May 13, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Apr 24, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 17, 2020 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Apr 17, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 17, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 17, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 17, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 18, 2019 | PBSR | Z | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST | Loading... |
| Dec 11, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 10, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 10, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 10, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 10, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 18, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 18, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 18, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 12, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 22, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| May 31, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| May 31, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| May 8, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| May 7, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 4, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 30, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 30, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 29, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Apr 18, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the prevention of disorders of the skeletal system; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of disorders of the central nervous system related to cancer, aging and metabolic diseases; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of disorders of the circulatory system related to aging; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of hormonal disorders and diabetes; pharmaceutical cough preparations; preparations for treating colds; pharmaceutical preparations for the treatment of flu and headache; pharmaceutical preparations for the treatment of stomach disorders; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for treating muscular and/or rheumatological diseases; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergies; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for use in oncology; diagnostic preparations and reagents for medical use in a clinic or medical laboratory; hormones; dietetic substances adapted for medical use, in particular, nutritional supplements, vitamin preparations, herbal supplements and preparations, nutritional drink mixes for use as meal replacements for medical use, meal replacement snacks for medical purposes; food and drinks for babies, infant formula and dietetic products for invalids, in particular food for babies, powdered milk for babies, foods for enteral feedings and dietetic foods adapted for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and technological services, namely, scientific research, analysis, testing, diagnosis and screening in the field of oncology and cancer research; research and development in the field of oncology, aging and metabolic diseases; scientific and industrial research and analysis services, namely, scientific research, analysis, testing in the field of medicine; biological research and analysis; scientific, clinical and medical research in the field of radiology, chemotherapy, pharmacotherapy, coronary artery bypass surgery; basic and clinical research in the field of genetics, stem cell, immunodeficiency and neurodegenerative diseases, proteomics, bioinformatics, neurobiology and molecular biology and diabetes; scientific research in the field of medicine; consultancy in the field of scientific analysis; none of the foregoing to include educational testing
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services, health care services in the field of oncology, aging and metabolic diseases, medical assistance, physical rehabilitation in the field of oncology; hospital services; consulting services in the field of medical care, namely, consultancy in the field of medical diagnosis, medical analysis and RNA or DNA analysis for cancer diagnosis and prognosis; consulting services relating to health care
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the wording "IFOM" in special characters and underlined by a line. Moreover, a stylized representation of a microscope starts from the line and partially overlaps with the letter "O".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
044